Blue Horseshoe: The Week in Review

For as long as we can remember following the Penny Stock Rumble, we can’t recall a time when a newsletter took the top spot on 3 out of 4 days, but with yesterday’s session, we did in fact reach that difficult achievement! We were anticipating our first ever hat-trick, and we were not disappointed. The following video outlines some of this week’s biggest successes:

Tiger Oil & Energy, Inc. TGRO

We started off Monday with TGRO, which traded as low as .36, and hit .635 on Tuesday for a 76% gain. It would then dip back to .38 before reversing again and surging as high as .62 yesterday for up to 63% on the rebound.

That brought this week’s cumulative gains from TGRO to a total of 139%.

BG Medicine, Inc. BGMD

Next came BGMD, which we spotted on Tuesday trading as low as .6115. We would witness this play running to a high of 1.70 by Wednesday, giving us the opportunity at 178% in possible gains.

CytRx Corp. CYTR

Last but not least, was Wednesday’s alert of CYTR, which looks like it could sprout legs again today. CYTR was as low as 3.45 at the time of our initial alert, and hit a high of 6.36 yesterday, racking in 84% in gains!

This morning, CYTR is gapping up once again, trading in the 6.55 range; if the breakout continues, consider it another triple-digit winner for us.

This was the play that gave us our third winning appearance on the Rumble:

Coronado BioSciences, Inc. CNDO

CNDO jumped out at us as a stock with a serious gap to fill on the chart. As you can see below, back in October the stock fell off a cliff from the $6-8 range all the way down to present levels.

This is a potential play that we’ll want to monitor closely moving forward, because a break of the 50DMA could very well lead to the filling of at least a portion of that gap, a move which would carry with it some significant gains.

With calls like these this week, we’ve made other newsletters obsolete! Nowhere else can you find both diversification into many areas of finance(from microcaps, to big-boards, to options-trading & more), and winning picks on such a consistent basis. Why would you go anywhere else? The word ‘quit’ is not in our vocabulary, which is why we’ll come back time and time again, providing our readers with the highest-quality picks available! We’re wrapping up another hugely successful week, so be sure to get back with us on Monday when we’ll do it all over again!

Extended Watchlist:
SFBR, PLUG, MACK, CLSN, ICLD, PVG, PTIX, ETAK

PHOT, CYTR, RNN & Extended Watchlist

Growlife, Inc. PHOT

We’re looking toward PHOT once again today, this old favorite of ours has provided us with opportinuties on countless occasions, and yesterday the company had some important news hit the wire. The company has enlisted the services of former Microsoft and Yahoo! exec, Marco Hegyi, to serve as Growlife’s President. The company is also set to begin a $40M capital infusion from a Nevada private investment group called CANX USA.

For these reasons, as well as the ripening conditions on the chart, we felt we needed to bring PHOT once again to the foreground of our discussions. We also prepared a video chart presentation for your convenience.

WOODLAND HILLS, Calif., Dec. 11, 2013 /PRNewswire via COMTEX/ — GrowLife, Inc. (OTCBB: PHOT), a diversified company operating in the legal cannabis industry which develops, markets and deploys products and services addressing the needs of legal cannabis growing and retail operations, including hydroponic growing equipment and retail support software, is pleased to announce that effective immediately, Marco Hegyi will assume the position of President and join the Board of Directors.

CytRx Corp. CYTR

CYTR put forth an exciting day of trading yesterday, with the stock undergoing several bounces. The stock opened at 3.90, and hit a subsequent high of 4.39 (+13%). We then saw a pullback to 3.45, and a bounce to 3.74 (+8%). This was followed by bounce from 3.55 to 4.02 (+13%), it pulled back again, and made another swing, this time from 3.60 to 4.05. (+13%)

Flippers certainly had the chance to have a field day with this one, with possible cumulative gains on the order of 47% presenting themselves.

Rexhan Pharmaceuticals, Inc. RNN

RNN came off of yesterday’s extended watchlist to provide our readers with a chance for a nice flip, trading from a low of .4026 to a high of .5179. That move represents an intraday gain of up to 29% on roughly 10X the posted 3mo. average volume.

Extended Watchlist:
OCLS, SNTA, BAXS, ASTC, AVNR
IMUC & SYN – Big gap downs, looking for possible bounces

BGMD, CYTR, ECTE, NRF, SIOCF & Extended Watchlist

BG Medicine, Inc. BGMD

BGMD helped us toward an extremely successful day of trading on Tuesday, and for the second day in a row, the number one spot of all newsletters on the Penny Stock Rumble.

After briefly touching a low of .6115, the stock exploded to a subsequent high of 1.29, marking a possible gain of up to 111% for sharp traders. This happened on more than 33x the 3mo. average volume, qualifying BGMD for momentum-mover status.

We’ll definitely want to follow the activity on this play today, it appears to want to gap up this morning, and could still have added gains in store for us.

Big Volume News Plays

The following three picks come off of our pre-market scanner with news out today, and we wanted to radar them. As we’ve shown with the past couple of days, our scans routinely reveal hidden gems that can provide us with an edge. We’ve taken the Penny Stock Rumble two days in a row, now let’s see that hat-trick!

CytRx Corp. CYTR
Reporting Highly Statistically Significant Positive Results from its Global Phase 2b Clinical Trial  >>>FULL PR

Echo Therapeutics, Inc. ECTE
Echo to receive a $10 million cash investment from MTIA and Platinum Partners –Company will withdraw the offering identified in recent Form S-1 filing>>>FULL PR

Northstar Reality Finance Corp. NRF
NorthStar Realty Finance announces plan to spin-off Asset Management Business into a separate publicly traded company in a tax-free transaction >>>FULL PR

Sierra Iron Ore Corp. SIOCF

While we have not been paid on SIOCF, we are aware of a paid promotion currently underway on the stock, so we thought we’d share that info.

Aside from that, the stock shows a chart that is looking ripe for a possible move. The accumulation/distribution has reached all-time highs, the RSI is coming off of being oversold, and is pushing through the 50-line. The MACD has also undergone a bullish cross.

Extended Watchlist:
GRPN, LIVE, OREX, ARIA, FREE,

Blue Horseshoe Afternoon Updates

For the second day in a row, performances from the subjects of our morning report have necessitated an afternoon follow-up. We managed to pile up several chances for big gains, even with the temporary glitch that left OTC trading halted for roughly an hour around lunchtime. It was the second such outage in the past month.

BG Medicine, Inc. BGMD

BGMD leads the way, with an excellent showing this morning. After seeing a low of .6115, the stock streaked upward and went on to hit highs in the 1.20’s. Gains approaching 100% have been possible thus far as BGMD has reached its highest levels since August.

Tiger Oil & Energy, Inc. TGRO

TGRO continued its uptrend this morning, topping out at .635. That marks a possible gain of 32% from today’s low, and a whopping 76% from Monday’s low following our initial alert.

Rambus, Inc. RMBS

RMBS was yet another winner this morning, coming off of our extended watchlist and powering its way to a 28% intraday gain from 8.25 to 10.57.

Navidea Biopharmaceuticals, Inc. NAVB

We put NAVB on our radars this morning after it popped up on our news feed, and has put up a solid move of 16%, with a daily range from 1.90-2.20.

Not signed up for our daily pre-market alerts yet? CLICK HERE and get your free subscription today!

TGRO, WMIH, BGMD, ZGNX, NAVB & Extended Watchlist

Tiger Oil & Energy, Inc. TGRO
–
For those of you who may have missed yesterday’s morning and afternoon reports on TGRO, the stock had a marquee day, putting up one of the best performances in the whole of the OTC Markets.

On more than 20x the 3mo. average volume, TGRO bulled its way upward throughout the day, starting at a low of .36 and reaching as high as .524, good for a strong intraday move and chance for up to a 46% profit. A strong close at .52 effectively puts us on the lookout for continued momentum this morning, though as always, traders should use caution on a stock that has seen such rapid increases.

Our timely mention of TGRO (coming just a day after the stock woke up from the dead) also put us at the top of Monday’s Penny Stock Rumble:

WMI Holdings Corp. WMIH

WMIH appeared on our Blue Horseshoe Stocks blog with yesterday afternoon’s alert, at which time the stock was trading in the 1.42 area. It would go on to experience a 27% move to 1.81 in the final hours of the session.

WMIH is now heading into uncharted territory, being the highest it’s ever been. We are going to be cautious for a pullback, and in that event we’d like to see the previous resistance, our alert price of 1.42, hold as support.

SEATTLE, Dec. 9, 2013 /PRNewswire/ — WMI Holdings Corp. (WMIH) (“WMI” or the “Company”) today announced that KKR & Co. L.P. has entered into a conditional commitment letter to make a strategic investment in the Company (the “Commitment Letter”), dated December 8, 2013. >>>Read Release

BG Medicine, Inc. BGMD

We’ve also got a new item for your tickers this morning. BGMD has news out, and looks set for an interesting session as the stock is gapping up in pre-market trading, coming off of recent lows and breaking above the 50DMA (.64), a recent area of resistance.

We’ll be monitoring BGMD today as it reacts to this morning’s announcement:

WALTHAM, Mass., Dec 10, 2013 (GLOBE NEWSWIRE via COMTEX) — BG Medicine, Inc. (Nasdaq:BGMD) announced today that the Centers for Medicare and Medicaid Services (CMS) have published the final determination of the 2014 Medicare national limitation amount for the Company’s galectin-3 blood test (analyte-specific CPT(R) Code 82777) at the amount of a crosswalked test (analyte-specific CPT(R) Code 84244) whose 2014 national limitation amount is $30.01. This national limitation amount will replace the galectin-3 blood test’s national limitation amount of $17.80 that was effective in 2013.

The following are plays with FDA-related news out this morning that we’ll want to watch closely today:

Zogenix, Inc. ZGNX
FDA Approval News out this morning, monitoring for potential breakout. >>>View PR

Navidea Biopharmaceuticals, Inc. NAVB
FDA has granted “Fast Track” status for the company’s lymph node detection test. >>>View PR

Extended Watchlist:
GERN, ARIA, CNDO, RMBS, VTNC, BLRX, NWBO

Get Our FREE Daily Reports!

SUBSCRIBE